BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24464645)

  • 1. Heart failure highlights in 2012-2013.
    Liu LC; Damman K; Lipsic E; Maass AH; Rienstra M; Westenbrink BD
    Eur J Heart Fail; 2014 Feb; 16(2):122-32. PubMed ID: 24464645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure highlights in 2011.
    Westenbrink BD; Damman K; Rienstra M; Maass AH; van der Meer P
    Eur J Heart Fail; 2012 Oct; 14(10):1090-6. PubMed ID: 22898804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association.
    Gopinathannair R; Cornwell WK; Dukes JW; Ellis CR; Hickey KT; Joglar JA; Pagani FD; Roukoz H; Slaughter MS; Patton KK
    Circulation; 2019 May; 139(20):e967-e989. PubMed ID: 30943783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmias in patients with ventricular assist devices.
    Boyle A
    Curr Opin Cardiol; 2012 Jan; 27(1):13-8. PubMed ID: 22123604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A device is not a drug.
    Konstam MA; Pina I; Lindenfeld J; Packer M
    J Card Fail; 2003 Jun; 9(3):155-7. PubMed ID: 12815563
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontiers of therapy for patients with heart failure.
    Liu SS; Monti J; Kargbo HM; Athar MW; Parakh K
    Am J Med; 2013 Jan; 126(1):6-12.e6. PubMed ID: 23260502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Arrhythmias and Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Devices.
    Ho G; Braun OÖ; Adler ED; Feld GK; Pretorius VG; Birgersdotter-Green U
    JACC Clin Electrophysiol; 2018 Jul; 4(7):847-859. PubMed ID: 30025683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of invasive electrophysiology in the management of patients with chronic heart failure.
    Landolina M; Cantù F; De Ferrari GM; Foresti S; Tavazzi L
    Heart Fail Monit; 2002; 3(2):49-59. PubMed ID: 12634880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New devices are helping transform coronary care.
    Wickelgren I
    Science; 1996 May; 272(5262):668-70. PubMed ID: 8614824
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy.
    Park SJ; Kushwaha SS; McGregor CG
    Clin Pharmacol Ther; 2012 Jan; 91(1):94-100. PubMed ID: 22113236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhythm management in pediatric heart failure.
    Berul CI; Dubin AM
    Congenit Heart Dis; 2006 Jul; 1(4):140-7. PubMed ID: 18377538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac arrhythmias in congestive heart failure.
    Kantharia BK
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):137-40. PubMed ID: 20136597
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage heart failure non-pharmacological therapy: recent advances in pacemakers, pressure monitors, pumps and other devices.
    Warriner DR; Sheridan PJ
    Postgrad Med J; 2014 Mar; 90(1061):164-70. PubMed ID: 24434615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.